Editorial
Awaiting the support of artificial intelligence in lung cancer
Translational Lung Cancer Research
2023;
12
(3)
:395-397
.
(31 March 2023)
TTF-1 and immune checkpoint therapy in non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(3)
:398-400
.
(31 March 2023)
Molecular mechanism and clinical outcome of non-small cell lung cancer patients with high BRAF expression
Translational Lung Cancer Research
2023;
12
(3)
:401-404
.
(31 March 2023)
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
Translational Lung Cancer Research
2023;
12
(3)
:405-407
.
(31 March 2023)
Original Article
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
Translational Lung Cancer Research
2023;
12
(3)
:408-426
.
(31 March 2023)
Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway
Translational Lung Cancer Research
2023;
12
(3)
:427-445
.
(31 March 2023)
Perioperative and oncological outcomes of uniportal versus three-port thoracoscopic segmentectomy for lung cancer: a propensity score matching analysis
Translational Lung Cancer Research
2023;
12
(3)
:446-459
.
(31 March 2023)
Real-world data on severe lung cancer: a multicenter retrospective study
Translational Lung Cancer Research
2023;
12
(3)
:460-470
.
(31 March 2023)
Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer
Translational Lung Cancer Research
2023;
12
(3)
:471-482
.
(31 March 2023)
Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort study
Translational Lung Cancer Research
2023;
12
(3)
:483-493
.
(31 March 2023)
Development and validation of a gene-based classification model for pN2 lung adenocarcinoma
Translational Lung Cancer Research
2023;
12
(3)
:494-509
.
(31 March 2023)
LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors
Translational Lung Cancer Research
2023;
12
(3)
:510-529
.
(31 March 2023)
The predictive accuracy of CT radiomics combined with machine learning in predicting the invasiveness of small nodular lung adenocarcinoma
Translational Lung Cancer Research
2023;
12
(3)
:530-546
.
(31 March 2023)
Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor
Translational Lung Cancer Research
2023;
12
(3)
:547-565
.
(31 March 2023)
The development and validation of a circulating tumor cells-based integrated model for improving the indeterminate lung solid nodules diagnosis
Translational Lung Cancer Research
2023;
12
(3)
:566-579
.
(31 March 2023)
APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
Translational Lung Cancer Research
2023;
12
(3)
:580-593
.
(31 March 2023)
Review Article
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
Translational Lung Cancer Research
2023;
12
(3)
:594-614
.
(31 March 2023)
Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review
Translational Lung Cancer Research
2023;
12
(3)
:615-628
.
(31 March 2023)
Case Report
Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report
Translational Lung Cancer Research
2023;
12
(3)
:629-636
.
(31 March 2023)
Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report
Translational Lung Cancer Research
2023;
12
(3)
:637-646
.
(31 March 2023)
Letter to the Editor
Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
Translational Lung Cancer Research
2023;
12
(3)
:647-648
.
(31 March 2023)
Role of adjuvant treatment in stage IB non-small cell lung carcinoma
Translational Lung Cancer Research
2023;
12
(3)
:649-652
.
(31 March 2023)
